Form 4: Calix CFO Cory Sindelar Executes Option Exercise and Share Sale Under 10b5-1 Plan

Calix, Inc.'s Chief Financial Officer, Cory Sindelar, exercised stock options and subsequently sold an equal number of common shares, as reported in a Form 4 filing.

Summary

• Cory Sindelar, Chief Financial Officer of Calix, Inc. (CALX), engaged in two transactions on June 30, 2025.
• Sindelar exercised stock options to acquire 10,000 shares of common stock at an exercise price of $5.05 per share.
• Concurrently, Sindelar sold 10,000 shares of common stock at a price of $52.00 per share.
• The sales were conducted pursuant to a previously established Rule 10b5-1 trading plan.
• Following these transactions, Sindelar's direct beneficial ownership of Calix common stock decreased from 86,285 shares to 76,285 shares.
• The stock option exercised was fully vested and exercisable on October 1, 2021.
• Sindelar retains 265,000 unexercised stock options after these transactions.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is routine and pre-planned, indicating no immediate negative implications. The executive realized a significant gain, which is positive for the individual, but the net sale reduces insider ownership slightly.

Positives

• The exercise of options indicates a prior grant of equity compensation, aligning management's interests with shareholders.
• The sale was executed at a significantly higher price ($52.00) than the exercise price ($5.05), indicating a substantial gain for the CFO.
• The transaction was conducted under a pre-established Rule 10b5-1 plan, which suggests a pre-planned sale not based on immediate inside information.

Negatives

• The sale of shares by a key executive (CFO) reduces their direct ownership stake in the company.
• A net reduction in direct beneficial ownership of common stock by 10,000 shares.

Future Outlook

The document does not provide forward-looking statements or guidance, as it is a report of past insider transactions.

Management Comments

• Sales reported on the Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan.

Industry Context

This Form 4 filing reflects a routine insider transaction, common across industries, where executives manage their equity compensation. The use of a Rule 10b5-1 plan is a standard practice for executives to sell shares in a pre-arranged manner, mitigating concerns about trading on material non-public information. Such transactions are typical for executives diversifying their personal portfolios or realizing gains from long-held equity awards.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan for executive stock sales is a widely adopted corporate governance practice across U.S. publicly traded companies, including technology firms like Calix, Inc. This practice aligns with best practices for insider trading compliance, similar to plans utilized by executives at companies such as Cisco Systems (CSCO) or Juniper Networks (JNPR).
• The exercise of vested stock options and subsequent sale of shares is a common method for executives to monetize their equity compensation, comparable to how executives at peer companies in the telecommunications equipment sector manage their long-term incentives.

Stakeholder Impact

• Shareholders: The sale by a CFO could be perceived as a slight reduction in management's direct equity alignment, though the 10b5-1 plan mitigates concerns of opportunistic selling. The transaction itself does not directly impact company operations or financial performance.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Recommendation

Keywords

Calix, CALX, Cory Sindelar, CFO, Form 4, SEC filing, insider trading, stock options, share sale, 10b5-1 plan, equity compensation